Kantonsspital St.Gallen

CORBUS: Lenabasum bei diffuser systemischer Sklerose

Silvia Forrer, Carina Hutz, Mira Bartz Batliner, Andrea Rubbert Roth & Thomas Neumann

abstract A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
type of project clinical studies
status ongoing - follow up
start of project 2018
end of project 2021
responsible person Prof. Dr. Rubbert-Roth